Barakat A J, Rennert O M
Department of Pediatrics and Nephrology, Georgetown University Medical Center, Washington, DC, USA.
J Nephrol. 2001 Jan-Feb;14(1):43-7.
Gitelman's syndrome (GS) is a heritable renal disorder characterized by hypomagnesemia, hypokalemia and hypocalciuria, and distinct from Bartter's syndrome (BS). As compared to those with BS, patients with GS present at an older age, and they have a milder clinical picture, normal or slightly decreased concentrating ability, reduced urinary excretion of calcium, and permanently decreased serum magnesium level. GS is caused by defective NaCl transport in the distal convoluted tubule, and linked to the gene encoding the thiazide sensitive Na-Cl-cotransporter located on chromosome 16q. Patients with BS, on the other hand, have mutations in the transporters in the thick ascending loop of Henle (NKCC2, ROMK, and C1C-Kb). Treatment of GS consists of magnesium salt replacement. Long term prognosis in terms of maintaining growth, preserving renal function and life expectancy is excellent.
吉特林综合征(GS)是一种遗传性肾脏疾病,其特征为低镁血症、低钾血症和低钙尿症,与巴特综合征(BS)不同。与BS患者相比,GS患者发病年龄较大,临床表现较轻,浓缩能力正常或略有下降,尿钙排泄减少,血清镁水平持续降低。GS是由远曲小管中氯化钠转运缺陷引起的,与位于16号染色体q上编码噻嗪类敏感钠氯共转运体的基因有关。另一方面,BS患者在髓袢升支粗段的转运体(NKCC2、ROMK和C1C-Kb)存在突变。GS的治疗包括补充镁盐。在维持生长、保留肾功能和预期寿命方面,长期预后良好。